Organisation: Position: Deadline Date: Location:


Weekly Roundup


Tall people more likely to develop blood clots

The taller you are, the more likely you may be to develop blood clots in the veins. In a study of more than 2m Swedish siblings, researchers found that the risk of venous thromboembolism – a type of blood clot that starts in a vein – as... September 13th, 2017


Children showing early signs of heart disease 16 years after 9/11

Sixteen years after the collapse of the World Trade Centre towers sent a cloud of toxic debris across Lower Manhattan, children living nearby who likely breathed in the ash and fumes are showing early signs of risk for future heart disease. This... September 13th, 2017


Factors in failing to start ART

With the goal of preventing HIV transmission and disease progression, US federal guidelines since early 2012 have suggested everyone who tests HIV positive should start on anti-retroviral treatment (ART). But, says a MD Mag report, not everyone... September 13th, 2017

Study looks at US youth transitioning to adult HIV care

While a number of qualitative studies have been completed looking at the specific challenges relating to HIV care transition for young people living with HIV moving into adult care, empirical data using objective clinical measures of outcomes... September 13th, 2017

New recommendations on ARVs for pregnant women living with HIV

New recommendations on antiretroviral drugs for pregnant women living with HIV can help women make more informed choices about benefits and harms, says a panel of international experts from University of Oslo, McMaster University, University of... September 13th, 2017

Dolutegravir may link to serious depression

Severe depression may be a side-effect of treatment with the anti-HIV drug dolutegravir, according to clinicians from The Netherlands , who report two cases of rapid onset of serious depression after initiation of therapy with the drug. The... September 13th, 2017


BCG protects against TB for longer than previously thought

Previously thought to be effective for 10-15 years, a new case-control study found that if given in early teenage years (12-13), the Bacillus Calmette-Guérin (BCG) vaccine protected over 50% of UK children against tuberculosis (TB) for at least 20... September 13th, 2017

New hyper-resistant superbug poses significant threat

The Partner State Key Laboratory of Chirosciences at the department of applied biology and chemical technology (ABCT) of Hong Kong Polytechnic University (PolyU) has discovered a newly emerged superbug, hyper-resistant and hypervirulent Klebsiella... September 13th, 2017

Childhood cancer survivors not getting HPV vaccinations

Childhood cancer survivors in the US are much less likely to have had human papillomavirus (HPV) vaccinations compared to their peers, despite being at increased risk from the virus, Reuters Health reports according to a new study. Only 24% of... September 13th, 2017



Stroke survivors should be checked for cancer development

Some stroke survivors may have 50% higher risk of underlying cancer, according to an observational study presented at the ESMO 2017 Congress in Madrid. “Post-mortem studies have suggested that cancer can develop after a stroke, but the... September 13th, 2017


Mediterranean diet plus water at least as good as PPIs for reflux

Among patients with laryngo-pharyngeal reflux, there was no significant difference in the reduction of reflux symptoms between patients treated with alkaline water and a plant-based, Mediterranean-style diet and those treated with proton pump... September 13th, 2017


Emoji fans take heart: Scientists pinpoint 27 states of emotion

A University of California Berkeley study challenges a long-held assumption in psychology that most human emotions fall within the universal categories of happiness, sadness, anger, surprise, fear and disgust. Using novel statistical models to... September 13th, 2017



Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.